Improving pharma procurement requires more than controlling costs. It requires better visibility into spend, stronger coordination across suppliers, and systems that support both research workflows and compliance requirements.
As organizations scale, procurement often becomes fragmented across disconnected teams, suppliers, and legacy tools, leading to reduced visibility, inconsistent purchasing decisions, and growing operational complexity. If you want a deeper breakdown of these challenges, see pharma procurement challenges impacting R&D.
Leading pharma teams are addressing this by adopting procurement best practices that improve efficiency while supporting the pace and precision of R&D.
Before focusing on tactics, it is important to define what "good" looks like in a modern R&D environment. A mature procurement function should move beyond simple transactions to become a strategic enabler of research.
Effective pharma procurement should enable:
For a broader look at how these goals fit into a larger operational framework, see our guide on pharma procurement strategy.
To transition from a disconnected approach to a centralized operating model, organizations should focus on these six areas:
Improving procurement performance requires clear metrics. By tracking key performance indicators (KPIs), teams can identify specific inefficiencies and continuously refine their procurement processes.
Leading pharma organizations prioritize tracking:
These best practices reflect a broader evolution toward centralized, data-driven procurement. By optimizing workflows and reducing complexity, pharma organizations can accelerate research timelines and improve compliance outcomes. This approach ensures procurement becomes a coordinated, scalable function across the organization.